A team of experienced entrepreneurs and drug developers committed to revolutionizing the standard of care for brain metastases.
Amie Phinney, PhD, MBA
co-Founder & Chief Executive Officer
Sheila Singh, MD, PhD, FRCS(C)
co-Founder & Chief Scientific Officer
Jakob Magolan, PhD
co-Founder & Head of Chemistry
Agata Kieliszek, PhD
co-Founder & Head of Biology and Operations